GSA Capital Partners’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-17
| Closed | -$14K | – | 1804 |
|
|
2022
Q2 | $14K | Buy |
+17
| New | +$14K | ﹤0.01% | 1326 |
|
|
2022
Q1 | – | Sell |
-218
| Closed | -$563K | – | 1759 |
|
|
2021
Q4 | $563K | Buy |
218
+113
| +108% | +$292K | 0.07% | 525 |
|
|
2021
Q3 | $480K | Buy |
105
+23
| +28% | +$105K | 0.05% | 720 |
|
|
2021
Q2 | $563K | Buy |
82
+64
| +356% | +$439K | 0.06% | 559 |
|
|
2021
Q1 | $133K | Sell |
18
-27
| -60% | -$200K | 0.02% | 974 |
|
|
2020
Q4 | $360K | Buy |
+45
| New | +$360K | 0.06% | 638 |
|